1195661

Kwabena (NMI) Ayesu, M.D. — FEI 3015396843

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 27, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Orlando, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
749821 CFR 312.66Unanticipated problems
756021 CFR 312.60FD-1572, protocol compliance